PRRT2 and Alzheimer disease: As was mentioned, YTX in the in vitro model of Alzheimer’s disease, primary cortical neurons 3xTg-AD, showed an improvement of Tau and β-amyloid levels through a mechanism related to the activation and translocation to the plasma membrane of cytosolic PKC.